Clinical significance of ≥ 50% PD‐L1 expression with the SP263 monoclonal antibody in non‐small cell lung cancer patients

DOI: 10.1111/1759-7714.12929

Keywords: Driver mutation, non‐small cell lung cancer, programmed death ligand 1, smoking

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text